Prescription drug · ANDA
Moxifloxacin NDC 16714-643
Moxifloxacin hydrochloride 5 mg/mL · Solution/ drops · Ophthalmic · NorthStar Rx LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 16714-643-01 | 1671406430116714064301 | 1 BOTTLE in 1 CARTON (16714-643-01) / 3 mL in 1 BOTTLEMarketed from Oct 4, 2017 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Moxifloxacin
- Generic name (nonproprietary)
- moxifloxacin
- Active ingredients
- Moxifloxacin hydrochloride — 5 mg/mL
- Dosage form
- Solution/ drops
- Route
- Ophthalmic
- Labeler
- NorthStar Rx LLCNDC labeler code 16714
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 206242
- Marketing start
- Listing expires
- Other FDA classes
- Quinolones (Chemical structure)
- Identifiers
- Product ID 16714-643_c11c970c-ffa6-4661-b515-708bae4eddd6SPL ID c11c970c-ffa6-4661-b515-708bae4eddd6SPL set ID cdc0b0eb-5f56-45c7-b9fd-364752a95ff1RxCUI 403818UNII C53598599T
- Pharmacologic class
- Quinolone Antimicrobial
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N416714064301followed by a unit qualifier and the quantityPackage 16714-0643-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Moxifloxacin ophthalmic solution is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: Corynebacterium species* Micrococcus luteus* Staphylococcus aureus Staphylococcus epidermidis Staphylococcus haemolyticus Staphylococcus hominis Staphylococcus warneri* Streptococcus pneumoniae Streptococcus viridans group Acinetobacter lwoffii* Haemophilus influenza Haemophilus parainfluenzae* Chlamydia trachomatis *Efficacy for this organism was studied in fewer than 10 infections. Moxifloxacin ophthalmic solution is a topical fluoroquinolone anti-infective indicated for the treatment of bacterial conjunctivitis caused by susceptible strains …
Excerpt only. Read the full label for complete information.
About NDC 16714-643
- What is NDC 16714-643?
- 16714-643 is the product NDC for Moxifloxacin, Moxifloxacin hydrochloride 5 mg/mL solution/ drops, listed with the FDA by NorthStar Rx LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Moxifloxacin.
- What is the active ingredient?
- Moxifloxacin hydrochloride.
- Who is the labeler?
- NorthStar Rx LLC, NDC labeler code 16714. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Moxifloxacin?
- 23 other product NDCs are listed under this name. See all Moxifloxacin NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Moxifloxacin products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Moxifloxacin | Moxifloxacin hydrochloride 400 mg/1 | Tablet, Film coatedOral | Macleods Pharmaceuticals Limited | 33342-322 | 33342-0322-0733342-0322-12 |
| Moxifloxacinmoxifloxacin hydrochloride | Moxifloxacin hydrochloride 400 mg/1 | Tablet, Film coatedOral | Solaris Pharma Corporation | 73473-903 | 73473-0903-30 |
| Moxifloxacin | Moxifloxacin hydrochloride monohydrate 5 mg/mL | Solution/ dropsOphthalmic | Advanced Rx Pharmacy of Tennessee, LLC | 80425-0379 | 80425-0379-01 |
| Moxifloxacin | Moxifloxacin hydrochloride 400 mg/1 | Tablet, Film coatedOral | Camber Pharmaceuticals, Inc. | 31722-845 | 31722-0845-0531722-0845-30 |
| Moxifloxacin | Moxifloxacin hydrochloride monohydrate 5 mg/mL | Solution/ dropsOphthalmic | Advanced Rx Pharmacy of Tennessee, LLC | 80425-0239 | 80425-0239-01 |
| Moxifloxacin | Moxifloxacin hydrochloride 5 mg/mL | Solution/ dropsOphthalmic | Direct Rx | 72189-334 | 72189-0334-05 |
| Moxifloxacin | Moxifloxacin hydrochloride monohydrate 5 mg/mL | Solution/ dropsOphthalmic | Direct Rx | 72189-321 | 72189-0321-05 |
| Moxifloxacin | Moxifloxacin hydrochloride 5 mg/mL | SolutionOphthalmic | Lupin Pharmaceuticals, Inc. | 68180-421 | 68180-0421-01 |
| Moxifloxacin | Moxifloxacin hydrochloride 5 mg/mL | Solution/ dropsOphthalmic | A-S Medication Solutions | 50090-8029 | 50090-8029-00 |
| Moxifloxacin | Moxifloxacin hydrochloride 5 mg/mL | Solution/ dropsOphthalmic | Aurobindo Pharma Limited | 65862-840 | 65862-0840-03 |
Other NDCs under ANDA 206242
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Moxifloxacin | Moxifloxacin hydrochloride 5 mg/mL | Solution/ dropsOphthalmic | A-S Medication Solutions | 50090-8029 |
| Moxifloxacin | Moxifloxacin hydrochloride 5 mg/mL | Solution/ dropsOphthalmic | Aurobindo Pharma Limited | 65862-840 |
| Moxifloxacin | Moxifloxacin hydrochloride 5 mg/mL | Solution/ dropsOphthalmic | Proficient Rx LP | 82804-055 |